Company & Sponsor Intelligence
New York State Psychiatric Institute
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials29
Recruiting1
Completed22
Countries2
Therapeutic footprint
adhdalzheimersanxietyautismdementia_otherdepressioneating_disordersneurodevelopmental_otherother_psychiatryschizophreniasubstance_use
Indexed studies
NCT05368493Air Pollution and Development in the Boricua Youth Study
neurodevelopmental_other · United StatesNA
neurodevelopmental_other · United StatesNA
NCT03048552Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3
substance_use · NA
substance_use · NA
NCT04640636IM Ketamine vs Midazolam for Suicidal ER Patients
depression · United StatesPHASE4
depression · United StatesPHASE4
NCT00627341A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Anorexia Nervosa
eating_disorders · United StatesPHASE1, PHASE2
eating_disorders · United StatesPHASE1, PHASE2
NCT01700829Ketamine in the Treatment of Suicidal Depression
depression · United StatesPHASE4
depression · United StatesPHASE4
NCT04710030Valacyclovir for Mild Cognitive Impairment
dementia_other · United StatesPHASE2
dementia_other · United StatesPHASE2
NCT01940237A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer
depression · United StatesNA
depression · United StatesNA
NCT00481988Treating Depression With Transcranial Direct Current Stimulation (tDCS)
depression · United StatesPHASE1, PHASE2
depression · United StatesPHASE1, PHASE2
NCT01706965Kuvan in People With Schizophrenia and Schizoaffective Disorder
schizophrenia · United StatesPHASE1, PHASE2
schizophrenia · United StatesPHASE1, PHASE2
NCT01222351Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT02596022The Effect of Glutamatergic Modulation on Cocaine Self-administration
other_psychiatry · PHASE2
other_psychiatry · PHASE2
NCT03637296Adapting Critical Time Intervention to Support Inpatient Medical Care Transition
schizophrenia · United StatesNA
schizophrenia · United StatesNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →